Kedrion Biopharma
Pietro Camici Bianconi is an accomplished finance professional with extensive experience in demand planning, financial control, and analysis across various industries. Currently serving as Demand Planning Sr Manager and Group Commercial Controlling Sr Manager at Kedrion Biopharma since January 2019, Pietro previously held significant roles at Cromology Italia, Siemens, and other organizations, focusing on budgeting, forecasting, and financial reporting. A strong educational background includes a Master CFO program at Università di Pisa and various degrees in Management Accounting and Economics, showcasing expertise in financial management and control.
This person is not in the org chart
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.